Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$47.98 - $54.4 $1,343 - $1,523
28 Added 0.05%
59,584 $3.23 Million
Q4 2023

Feb 08, 2024

SELL
$48.48 - $57.85 $2.87 Million - $3.42 Million
-59,142 Reduced 49.83%
59,556 $3.06 Million
Q3 2023

Oct 17, 2023

BUY
$57.89 - $64.73 $3.19 Million - $3.56 Million
55,046 Added 86.48%
118,698 $6.89 Million
Q2 2023

Aug 02, 2023

BUY
$63.71 - $70.74 $4,523 - $5,022
71 Added 0.11%
63,652 $4.07 Million
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $172,423 - $195,566
-2,624 Reduced 3.96%
63,581 $4.41 Million
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $27,528 - $32,598
-402 Reduced 0.6%
66,205 $4.76 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $163 - $96,357
-1,254 Reduced 1.85%
66,607 $4.74 Million
Q2 2022

Aug 05, 2022

BUY
$72.62 - $79.98 $690,688 - $760,689
9,511 Added 16.3%
67,861 $5.23 Million
Q1 2022

May 12, 2022

SELL
$61.48 - $73.72 $67,505 - $80,944
-1,098 Reduced 1.85%
58,350 $4.26 Million
Q4 2021

Jan 27, 2022

SELL
$53.63 - $62.52 $25,581 - $29,822
-477 Reduced 0.8%
59,448 $3.71 Million
Q3 2021

Oct 15, 2021

BUY
$59.17 - $69.31 $41,419 - $48,517
700 Added 1.18%
59,925 $3.55 Million
Q2 2021

Jul 22, 2021

SELL
$61.91 - $67.42 $196,316 - $213,788
-3,171 Reduced 5.08%
59,225 $3.96 Million
Q1 2021

May 07, 2021

BUY
$59.34 - $66.74 $163,244 - $183,601
2,751 Added 4.61%
62,396 $3.94 Million
Q4 2020

Jan 19, 2021

BUY
$57.74 - $65.43 $2.44 Million - $2.77 Million
42,307 Added 244.01%
59,645 $3.7 Million
Q3 2020

Oct 09, 2020

BUY
$57.43 - $63.64 $105,211 - $116,588
1,832 Added 11.81%
17,338 $1.05 Million
Q2 2020

Jul 15, 2020

SELL
$54.82 - $64.09 $196,694 - $229,954
-3,588 Reduced 18.79%
15,506 $911,000
Q1 2020

Apr 16, 2020

BUY
$46.4 - $67.43 $142,865 - $207,616
3,079 Added 19.23%
19,094 $1.06 Million
Q4 2019

Jan 09, 2020

BUY
$49.21 - $64.19 $335,907 - $438,160
6,826 Added 74.28%
16,015 $1.03 Million
Q3 2019

Nov 08, 2019

SELL
$42.77 - $50.71 $8,853 - $10,496
-207 Reduced 2.2%
9,189 $466,000
Q2 2019

Jul 19, 2019

SELL
$44.62 - $49.34 $355,130 - $392,697
-7,959 Reduced 45.86%
9,396 $4.26 Million
Q1 2019

May 15, 2019

SELL
$45.12 - $53.8 $196,948 - $234,837
-4,365 Reduced 20.1%
17,355 $8.28 Million
Q4 2018

Feb 05, 2019

BUY
$48.76 - $63.23 $455,467 - $590,631
9,341 Added 75.46%
21,720 $1.13 Million
Q3 2018

Oct 19, 2018

SELL
$55.19 - $62.25 $35,100 - $39,591
-636 Reduced 4.89%
12,379 $769,000
Q2 2018

Aug 06, 2018

SELL
$50.53 - $62.98 $29,105 - $36,276
-576 Reduced 4.24%
13,015 $720,000
Q1 2018

May 08, 2018

SELL
$59.92 - $68.98 $109,174 - $125,681
-1,822 Reduced 11.82%
13,591 $860,000
Q4 2017

Jan 30, 2018

BUY
$59.94 - $65.35 $119 - $130
2 Added 0.01%
15,413 $980,000
Q3 2017

Oct 31, 2017

BUY
$55.23 - $63.74 $851,149 - $982,297
15,411
15,411 $983,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Meridian Wealth Management, LLC Portfolio

Follow Meridian Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meridian Wealth Management, LLC with notifications on news.